News

Implanted Device Shortens HF Hospitalization


 

But other experts are concerned about paying for this intensive approach to patient management.

“The implications are profound regarding the cost of care,” commented Dr. Harlan M. Krumholz, professor of medicine and epidemiology at Yale University, New Haven, Conn. “How should we decide which patients should get this?”

“We're developing models of how to use it,” said Dr. Bourge, who acknowledged that not all physicians would have the expertise or time to review so many pressure measurements for their patients.

Because of this, researchers are working on developing an automated way to review the large number of intracardiac pressure measurements that are made in each patient.

Pages

Recommended Reading

Oral Inotrope Shown Safe, but Not Effective
MDedge Cardiology
A-HeFT Drug Combo Reverses LV Remodeling
MDedge Cardiology
Perindopril Stalls Post-MI Ventricular Remodeling
MDedge Cardiology
Hypothermia Linked to Heart Failure Death
MDedge Cardiology
Drug Order Shown Irrelevant for Heart Failure
MDedge Cardiology
Nesiritide Doesn't Affect Renal Function in Stable HF Patients
MDedge Cardiology
Ularitide Found Safe, Effective in HF
MDedge Cardiology
High-Dose Atorvastatin Cuts HF Hospitalization
MDedge Cardiology
Admission BNP a Flag for Mortality in Heart Failure
MDedge Cardiology
Home HF Monitoring System Improves Outcomes
MDedge Cardiology